Why is it crucial to reintegrate pathology into cancer research?

Abstract

The integration of pathology with molecular biology is vital if we are to enhance the translational value of cancer research. Pathology represents a bridge between medicine and basic biology, it remains the gold standard for cancer diagnosis, and it plays an important role in discovery studies. In the past, pathology and cancer research were closely associated; however, the molecular biology revolution has shifted the focus of investigators toward the molecular alterations of tumors. The reductionist approach taken in molecular studies is producing great insight into the inner workings of neoplasia, but it can also minimize the importance of histopathology and of understanding the disease as a whole. In turn, pathologists can underestimate the role of molecular studies in developing new ancillary techniques for clinical diagnosis. A multidisciplinary approach that integrates pathology and molecular biology within a translational research system is needed. This process will require overcoming cultural barriers and can be achieved through education, a more effective incorporation of pathology into biological research, and conversely an integration of biological research into the pathology laboratory.

Of Mice and Women: A Comparative Tissue Biology Perspective of Breast Stem Cells and Differentiation

“…Furthermore, the insights gleaned from studying normal cellular lineages must be related to disease states [ 3 , 4 ]. This integration process has not been always successful, partly due to lack of communication between different fields of research, decreasing number and lack of involvement of CTB experts [ 1 , 5 – 8 ]. Here, we examine some of the factors that contribute to these challenges.…”

The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of Epcam in Breast Cancer

“…Surgical pathology has become the ‘gold standard’ for the diagnosis of tumors [1]. When morphological features of the tumor are not adequate for a definitive diagnosis, immunohistochemistry (IHC) may be of benefit [2].…”

Contribution of Pathologists in Leading Clinical Cancer Research Through Interdisciplinary Collaboration in Saudi Arabia

“…The involvement of pathologists is essential in preclinical, as well as in clinical cancer research [ 5 , 12 ]. In Saudi Arabia, most of the clinical cancer research was led by pathologists [ 8 ].…”